Ertl S, Deckart H, Tautz M
Eur J Nucl Med. 1984;9(5):241-4. doi: 10.1007/BF00448547.
For the years 1978 and 1981 we compared the radiation dose for the patients examined by in vivo methods after administration of radiopharmaceuticals (27 procedures). The somatic effective dose equivalent, the effective collective dose, the somatic radiation risk, and the number of induced malignancies were calculated according to ICRP publication No. 26. All the procedures give rise to a radiation-induced somatic risk from the 4th up the 7th order. In recent years we have seen an increase of the application of 99mTc compounds and a decrease in the use of 131I-sodium iodide. A comparison of the results for the two years shows the expected reduction of radiation dose and risk.
在1978年和1981年，我们比较了放射性药物给药后采用体内方法检查的患者所接受的辐射剂量（27例检查）。根据国际辐射防护委员会第26号出版物计算了躯体有效剂量当量、有效集体剂量、躯体辐射风险以及诱发恶性肿瘤的数量。所有这些检查所产生的辐射诱发躯体风险处于4级到7级。近年来，我们发现99mTc化合物的应用有所增加，而碘化钠131I的使用有所减少。这两年结果的比较显示出辐射剂量和风险如预期般降低。
